Selected biomarkers of depression: what are the effects of cytokines and inflammation
Open accessThe DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index; 27 of the 178 sources its claims cite were checked for support.
Abstract
Depression is one of the leading mental illnesses worldwide and lowers the quality of life of many. According to WHO, about 5% of the worldwide population suffers from depression. Newer studies report a staggering global prevalence of 27.6%, and it is rising. Professionally, depression belonging to affective disorders is a psychiatric illness, and the category of major depressive disorder (MDD) comprises various diagnoses related to persistent and disruptive mood disorders. Due to this fact, it is imperative to find a way to assess depression quantitatively using a specific biomarker or a panel of biomarkers that would be able to reflect the patients’ state and the effects of therapy. Cytokines, hormones, oxidative stress markers, and neuropeptides are studied in association with depression. The latest research into inflammatory cytokines shows that their relationship with the etiology of depression is causative. There are stronger cytokine reactions to pathogens and stressors in depression. If combined with other predisposing factors, responses lead to prolonged inflammatory processes, prolonged dysregulation of various axes, stress, pain, mood changes, anxiety, and depression. This review focuses on the most recent data on cytokines as markers of depression concerning their roles in its pathogenesis, their possible use in diagnosis and management, their different levels in bodily fluids, and their similarities in animal studies. However, cytokines are not isolated from the pathophysiologic mechanisms of depression or other psychiatric disorders. Their effects are only a part of the whole pathway.
Overview
CoChat Summary
TL;DR
This narrative review summarizes evidence that inflammatory cytokines such as IL-1β, IL-6, IL-12, IL-18, IFN-γ, and TNF are altered in depression and may serve as biomarkers for diagnosis, severity, and treatment response. It concludes that cytokines are viable research targets, but findings are inconsistent and causality remains unclear.
Key findings
- Cytokines including IL-1β, IL-6, IL-12, IL-18, IFN-γ, and TNF-α are repeatedly associated with depression; the review concludes they are viable options for quantitative depression research, preferably using non-invasively collected bodily fluids.
- Meta-analytic evidence cited includes elevated IL-3 in depression (107 studies, 5,166 patients and 5,083 controls), elevated IL-12 in an 82-study meta-analysis, and a mean sIL-2R difference of 0.555 U/mL between healthy subjects and MDD patients.
- Some markers relate to treatment: elevated baseline TNF was associated with worse antidepressant outcomes; IL-17A was elevated in MDD non-responders; IL-13 showed a 69% reduction at week 52 of SSRI treatment; multi-assay panels including sTNFR2 achieved 69.2% correct classification (62.5% sensitivity, 82.5% specificity) and, in another panel, 91.1% sensitivity and 81.3% specificity for MDD.
- Findings are often contradictory: IL-1β, IL-6, IL-8, IL-10, CCL2, CCL5, and TNF show conflicting elevations or decreases across studies, with unclear relationships between peripheral and CSF levels and between animal and human results.
Methods
- Narrative review of recent data on cytokines as markers of depression, covering their roles in pathogenesis, diagnosis, management, bodily fluid levels, and similarities in animal studies.
- The paper synthesizes human clinical studies, meta-analyses, systematic reviews, and animal models, organized cytokine by cytokine.
- No systematic search strategy, inclusion criteria, or quality assessment is stated in the paper.
Limitations
- The paper states that cytokines are not isolated from the pathophysiologic mechanisms of depression or other psychiatric disorders and that their effects are only part of the whole pathway.
- The paper repeatedly notes inconsistent findings, unclear cause-versus-consequence relationships, and differences between peripheral and central levels or between animal models and human patients.
- Evident from the text: as a narrative review without a described systematic search or quality appraisal, it may be subject to selection and interpretation bias, and many cited studies are small or heterogeneous.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
22 Valid · 0 Not valid · 113 Not checked · 23 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A meta-analysis concluded that IL-1β was significantly elevated in patients with depression and Alzheimer’s disease (AD), while IL-6 was elevated only in patients with depression [38].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
What the sources say
- Partly supportedcites [38] Ng A. Tam W.W. Zhang M.W. Ho C.S. Husain S.F. McIntyre R.S. Ho R.C. IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s Disease: Systematic Review and Meta-Analysis Sci. Rep. 2018 8 12050 10.1038/s41598-018-30487-6 30104698 PMC6089986 sourceExperimental — accuracy not yet measured
The Results (Meta-Analysis for Elderly with and without Alzheimer’s disease) report significantly higher peripheral IL-1β in elderly patients with Alzheimer’s disease than in controls (p = 0.041). The Discussion qualifies this as significant before Bonferroni adjustment, and the Conclusion says that after correction for multiple testing, only IL-6 in elderly patients with depression remained significantly elevated. The citing sentence omits that qualification. (LLM, conf=0.90)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“P2X7 inhibition has been associated with antidepressant-like effects, and IL-1β knockout mice failed to express these receptors [48,49].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
What the sources say
- Not checked yetcites [48] Seil M. Ouaaliti M.E. Abdou Foumekoye S. Pochet S. Dehaye J. Distinct Regulation by Lipopolysaccharides of the Expression of Interleukin-1β by Murine Macrophages and Salivary Glands Innate Immun. 2012 18 14 24 10.1177/1753425910377101 20682589 source
- Could not verifycites [49] Clark A.K. Staniland A.A. Marchand F. Kaan T.K.Y. McMahon S.B. Malcangio M. P2X7-Dependent Release of Interleukin-1 and Nociception in the Spinal Cord Following Lipopolysaccharide J. Neurosci. 2010 30 573 582 10.1523/JNEUROSCI.3295-09.2010 20071520 PMC2880485 sourceExperimental — accuracy not yet measured
The Results section on LPS-induced mechanical hypersensitivity reports that P2X7 antagonists prevented hyperalgesia, not that they had antidepressant-like effects. A search for depression and antidepressant-like behavior found no passage addressing that outcome in our copy; page numbers were unavailable. (LLM, conf=0.75)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Elomaa et al. described elevated IL-5 levels in 58 patients with MDD, though a later meta-analysis did find changes in levels of IL-5 to be inconclusive in depressed patients.”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.5. Interleukin-5
What the sources say
- Supportedcites [35] Köhler C.A. Freitas T.H. Maes M. de Andrade N.Q. Liu C.S. Fernandes B.S. Stubbs B. Solmi M. Veronese N. Herrmann N. Peripheral Cytokine and Chemokine Alterations in Depression: A Meta-Analysis of 82 Studies Acta Psychiatr. Scand. 2017 135 373 387 10.1111/acps.12698 28122130 source
The 'Other mediators' section of our copy lists IL-5 among mediators measured in at least three studies and states that levels 'did not significantly differ between individuals with MDD and HCs'. Table 1 gives the IL-5 primary meta-analysis as 4 studies (198 MDD vs 322 controls), Hedge's g = 0.396 (95% CI -0.072 to 0.865), P = 0.097, I² = 82.1% — a non-significant, borderline estimate with large heterogeneity, i.e. no established IL-5 change in depression. The citing paraphrase renders the paper's null/borderline result as 'inconclusive', which is a fair (if slightly hedged) restatement of what this 2017 meta-analysis reports for IL-5 in MDD patients. (LLM, conf=0.86)
- Not checked yetcites [77] Ho H.-Y. Chin-Hung Chen V. Tzang B.-S. Hsieh C.-C. Wang W.-K. Weng Y.-P. Hsu Y.-T. Hsaio H.-P. Weng J.-C. Chen Y.-L. Circulating Cytokines as Predictors of Depression in Patients with Breast Cancer J. Psychiatr. Res. 2021 136 306 311 10.1016/j.jpsychires.2021.02.037 33636686 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Female rats with lower IL-8 levels are more susceptible to medication and electroconvulsive therapy (ECT) [92,93].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.7. Interleukin-8
What the sources say
- Partly supportedcites [92] Kruse J.L. Vasavada M.M. Olmstead R. Hellemann G. Wade B. Breen E.C. Brooks J.O. Congdon E. Espinoza R. Narr K.L. Depression Treatment Response to Ketamine: Sex-Specific Role of Interleukin-8, but Not Other Inflammatory Markers Transl. Psychiatry 2021 11 167 10.1038/s41398-021-01268-z 33723220 PMC7960960 sourceExperimental — accuracy not yet measured
The Introduction and Discussion report that lower baseline IL-8 was associated with better ECT response in female patients. The Discussion also reports an association with antidepressant-medication response, but says sex differences were not evaluated in those studies. These findings concern people, not female rats. (LLM, conf=0.90)
- Partly supportedcites [93] Kruse J.L. Olmstead R. Hellemann G. Wade B. Jiang J. Vasavada M.M. Brooks Iii J.O. Congdon E. Espinoza R. Narr K.L. Inflammation and Depression Treatment Response to Electroconvulsive Therapy: Sex-Specific Role of Interleukin-8 Brain Behav. Immun. 2020 89 59 66 10.1016/j.bbi.2020.05.069 32479994 PMC7572496 sourceExperimental — accuracy not yet measured
The Discussion reports that lower baseline IL-8 was associated with improvement after ECT in female patients, not female rats. It also reports lower baseline IL-8 among antidepressant-medication responders in a meta-analysis, but says that analysis did not evaluate sex. Thus neither the rat population nor a female-specific medication response is supported. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“IL-4-driven Arg1+ microglia in the hippocampus trigger brain-derived neurotrophic factor (BDNF)-driven neurogenesis in reaction to stress, resulting in improved resilience to stress-induced depression.”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.4. Interleukin-4
What the sources say
- Supportedcites [69] Zhang J. Rong P. Zhang L. He H. Zhou T. Fan Y. Mo L. Zhao Q. Han Y. Li S. IL4-Driven Microglia Modulate Stress Resilience through BDNF-Dependent Neurogenesis Sci. Adv. 2021 7 eabb9888 10.1126/sciadv.abb9888 33731342 PMC7968840 source
The Discussion states that IL4-driven Arg1+ microglia ameliorate chronic stress–induced depressive-like behaviors in mice through BDNF-dependent hippocampal neurogenesis. The Results section on stress-induced depressive-like behaviors also reports that blocking BDNF signaling or neurogenesis abolished the protective effect. (LLM, conf=0.93)
- Not checked yetcites [70] Wachholz S. Knorr A. Mengert L. Plümper J. Sommer R. Juckel G. Friebe A. Interleukin-4 Is a Participant in the Regulation of Depressive-like Behavior Behav. Brain Res. 2017 326 165 172 10.1016/j.bbr.2017.03.020 28315756 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
105 more claims · 13 with their cited sources checked
Create a free account to see all 158 claims and to verify the 151 references still open.
- It may state two separate claims as one. 38
- Probably not a substantial claim. 11
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar associations have been reported with cytokines and neuropeptides in depression (13).”
From Retrospective evaluation of novel serum inflammatory biomarkers in first-episode psychiatric disorders: diagnostic potential and immune dysregulation (2024) · doi:10.3389/fpsyt.2024.1442954 · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.11. Interleukin-13
“The above-cited meta-analysis by Köhler et al. underpins the association between peripheral IL-13 elevation and MDD [14].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > References
“14. Siwek M. Sowa-Kućma M. Dudek D. Styczeń K. Szewczyk B. Kotarska K. Misztak P. Pilc A. Wolak M. Nowak G. Oxidative Stress Markers in Affective Disorders”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
“The use of intrahippocampal IL-1RA causes downregulation of brain-derived neurotrophic factor (BDNF) in individuals experiencing social isolation [52].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > References
“Brain-Derived Neurotrophic Factor MRNA Downregulation Produced by Social Isolation Is Blocked by Intrahippocampal Interleukin-1 Receptor Antagonist”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.19. Tumor Necrosis Factor
“namely c.-1211T > C—TNF-α (rs1799964)”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.19. Tumor Necrosis Factor
“the C allele in the C/T genotype of rs179964 was associated with positive treatment outcomes and low serum levels of TNF.”
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475 · cited 1×
“Cytokines, hormones, oxidative stress markers, and neuropeptides have been studied in association with depression [8].”
BackgroundSantomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444 · cited 1×
“6%, and while the prevalence is rising globally, the late SARS-CoV-2 pandemic caused problems, especially in middle- and low-income countries [3,4].”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“Levels of cytokines have been found significantly altered in depression, and patients, even if otherwise clinically healthy, show elevated or decreased levels of various cytokines and their soluble receptors in bodily fluids [18].”
BackgroundThe regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
Biological basis of the behavior of sick animals
Hart, B. L. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80004-6 · Cited by 2,223 · cited 1×
“This cytokine was first implicated in the etiology of sickness behavior and later linked to depressive disorder along with IL-6 and TNF [36,37].”
BackgroundPeripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443
Research works printed but not linked: 10
- Bains N. Abdijadid S. Major Depressive Disorder StatPearls StatPearls Publishing Treasure Island, FL, USA 2022 32644504
- IL3 Interleukin 3 [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3562 (accessed on 18 December 2022)
- IL12A Interleukin 12A [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3592 (accessed on 30 November 2022)
- IL12B Interleukin 12B [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3593 (accessed on 30 November 2022)
- IL13 Interleukin 13 [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3596 (accessed on 30 November 2022)
- IL17A Interleukin 17A [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3605 (accessed on 13 December 2022)
- IL18 Interleukin 18 [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3606 (accessed on 30 November 2022)
- CCL2 C-C Motif Chemokine Ligand 2 [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/6347 (accessed on 13 December 2022)
- TNF Tumor Necrosis Factor [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/7124 (accessed on 30 November 2022)
- TNFRSF1B TNF Receptor Superfamily Member 1B [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/7133 (accessed on 30 November 2022)
Cited by
Yin, Y., Ju, T., Zeng, D., Duan, F., Zhu, Y., Liu, J., Li, Y., & Lu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107322 · Cited by 179
Cardiovascular disease and depression: a narrative review
Li, X., Zhou, J., Wang, M., Yang, C., & Sun, G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1274595 · Cited by 129
Pathogenesis and treatment of depression: Role of diet in prevention and therapy
Mrozek, W., Socha, J., Sidorowicz, K., Skrok, A., Syrytczyk, A., Piątkowska‐Chmiel, I., & Herbet, M. (2023) · Nutrition · doi:10.1016/j.nut.2023.112143 · Cited by 78
The characteristics of anhedonia in depression: a review from a clinically oriented perspective
Wu, C., Mu, Q., Gao, W., & Lu, S. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03310-w · Cited by 86
Inflammatory biomarkers in depression: scoping review
Paganin, W., & Signorini, S. (2024) · BJPsych Open · doi:10.1192/bjo.2024.787 · Cited by 57
Xi, L., Fang, F., Zhou, J., Xu, P., Zhang, Y., Zhu, P., Tu, J., & Sun, Q. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.027 · Cited by 51
Sun, L., Ma, S., Yu, Y., Li, X., Wei, Q., Min, L., & Rong, P. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14614 · Cited by 45
Metabolic Health and Disease: A Role of Osteokines?
Shimonty, A., Bonewald, L. F., & Huot, J. R. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01093-0 · Cited by 43
Microbiota–gut–brain axis: Natural antidepressants molecular mechanism
Lu, Y., Yu, X., Wang, Z., Kong, L., Jiang, Z., Shang, R., Zhong, X., Lv, S., Zhang, G., Gao, H., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156012 · Cited by 42
Alberti, A., Coelho, D. R. A., Vieira, W. F., Iser, B. P. M., Lampert, R., Traebert, E., da Silva, B. B., de Oliveira, B. H., Leão, G. M., de Souza, G., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12091994 · Cited by 55
Wang, J., Xie, J., He, F., Wu, W., Ke Cheng, X. U., Ren, Y., Chen, J., & Xie, P. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107938 · Cited by 35
Modesti, M. N., Arena, J. F., CASALE, A. D., Gentile, G., Borro, M., Parmigiani, G., Simmaco, M., Guariglia, C., & Ferracuti, S. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02512-x · Cited by 33
“Additionally, peripheral biomarkers encompassing cytokines [12], markers of oxidative stress [13, 14], and lipids [15] have been explored.”
Zhang, S., Hu, Y., Zhao, Y., Feng, Y., Wang, X., Miao, M., & Miao, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155729 · Cited by 30
Astrocyte-derived CCL5-mediated CCR5 + neutrophil infiltration drives depression pathogenesis
Yao, H. P., Jiang, S., Jiao, Y., Zhou, Z.-Y., Zhu, Z., Wang, C., Zhang, K., Ma, T. F., Hu, G., Du, R., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt6632 · Cited by 31
“Psychosocial stressors have been shown to increase peripheral cytokine production, which may contribute to the development of depression ( 12 – 14 ).”
Larrea, A., Sánchez-Sánchez, L., Díez-Martín, E., Elexpe, A., Torrecilla, M., Astigarraga, E., & Barreda‐Gómez, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061727 · Cited by 34
“Therefore, the identification of anti-inflammatory compounds that can positively modulate mitochondrial function represents a promising area of research that could have significant clinical implications in the future.”
BackgroundAdvances in biosensors for major depressive disorder diagnostic biomarkers
Dong, T., Yu, C., Mao, Q., Han, F., Yang, Z., Yang, Z., Pires, N. M. M., Wei, X., Jing, W., Lin, Q., et al. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116291 · Cited by 27
Ho, C. S. H., Wang, J., Tay, G. W. N., Ho, R., Lin, H., Li, Z., & Chen, N. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03224-7 · Cited by 27
Recent advances and perspectives of small molecule fluorescent probes imaging in depression research
Zhu, H., Ma, Z., Wang, X., Ji, L., & Zhu, B. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216963 · Cited by 25
Gézsi, A., der Auwera, S. V., Mäkinen, H., Eszlári, N., Hullám, G., Nagy, T., Bonk, S., González, R., Gonda, X., Garvert, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51467-7 · Cited by 27
“The fi ndings obtained by using our approach con fi rmed that in fl ammatory signalling is part of the underlying aetiology of depression 32 in Cluster 7.”
Mechanistic insights regarding neuropsychiatric and neuropathologic impacts of air pollution
Rentschler, K. M., & Kodavanti, U. P. (2024) · Critical Reviews in Toxicology · doi:10.1080/10408444.2024.2420972 · Cited by 31
“…the increase in of inflammatory cytokines can cause sickness-like behavior, which in the long term, may induce chronic neuroinflammation prompting the possible development of major depression, or psychotic disorders such as schizophrenia and bipolar disorder (Hart 1988; Harsanyi et al. 2022).”
The effect of exercise on depression and gut microbiota: Possible mechanisms
Yao, M., Qu, Y., Zheng, Y., & Guo, H. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111130 · Cited by 29
“…symptoms, but moderate-intensity exercise tends to reduce pro-inflammatory cytokine like TNF-α , while high-intensity exercise may increase TNF-α and IL-6. levels, potentially diminishing the extent of depression remission (Raison et al., 2006; Paolucci et al., 2018; Harsanyi et al., 2022).”
Li, W., Huo, S., Yin, F., Wu, Z., Zhang, X., Wang, Z., & Cao, J. (2024) · BMC Public Health · doi:10.1186/s12889-024-21161-w · Cited by 33
Abnormalities of lipid metabolism in the progression and treatment of depression
Luan, X., Wang, X., Shi, Y., Zhang, X., Wang, Y., Zhou, M., Wu, Z., Liu, Z., Li, X., Zhang, L., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1589663 · Cited by 30
Chan, K. W., Hebert, J., Radford‐Smith, D. E., Anthony, D. C., & Burnet, P. W. J. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109565 · Cited by 23
“Dysregulation of the immune response, particularly the secretion of pro-inflammatory cytokines, has been proposed to contribute to the pathophysiology of mood disorders (Harsanyi et al., 2022).”
BackgroundMilic, J., Jovic, S., & Sapic, R. (2025) · Genes · doi:10.3390/genes16050487 · Cited by 19
“…activity [38] and lipid peroxidation [39], monitoring of adenosine levels of 3 ′ ,5 ′ -monophosphate [40], activity of protein kinases [41], monitoring of pro-inflammatory cytokine levels [42], changes in tryptophan [43], kynurenine [44], insulin [45], and determination of gene polymorphisms [46].”
Circulating Blood-Based Proteins in Psychopathology and Cognition: A Mendelian Randomization Study
Bhattacharyya, U., John, J., Lam, M., Fisher, J., Sun, B. B., Baird, D. A., Burgess, S., Chen, C., & Lencz, T. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.0033 · Cited by 22
Song, X., Zhu, H., Chen, Z., Wang, Y., Zhang, J., Wang, Y., Rong, P., & Wang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1536056 · Cited by 28
Kim, K. Y., Shin, K. Y., & Chang, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813907 · Cited by 25
“IL-1 β , along with IL-6 and TNF, has been linked to sickness behavior and implicated in depressive disorders [57].”
BackgroundCoronelli, M. M., Coppi, F., & Mattioli, A. V. (2023) · Future Cardiology · doi:10.2217/fca-2023-0030 · Cited by 20
Liu, A., Hong, P.-Y., Su, B., Wu, J.-H., & Chen, Z. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.02.022 · Cited by 18
Gędek, A., Modrzejewski, S., Materna, M., Iwański, M., Wichniak, A., & Dominiak, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110362 · Cited by 27
Across Barriers: Blood–Brain and Gut Barrier Signaling in Psychiatric Disorders
Binder, L. B., Bevilacqua, L. M., Thomassen, F. G. L., Lebel, M., Jensen, B. A. H., & Ménard, C. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70282 · Cited by 20
“Elevated levels of pro-inflammatory cytokines like IL-1β, IL-6, and IFN-γ correlate with greater MDD severity and/or vulnerability (Harsanyi et al. 2022).”
Chen, J., Huang, Y. X., & Li, X. (2024) · Brain and Behavior · doi:10.1002/brb3.3467 · Cited by 19
“Previous studies have reported that serum cytokines (Harsanyi et al., 2023), C-reactive protein(CRP) (Horna et al., 2018), high-density lipoprotein cholesterol (HDL-C) (Akboga et al., 2016; Wu et al., 2013), complete blood count test indicators (Zhu et al., 2023) including lymphocytes, neutrophils,…”
BackgroundWang, X. X., Ji, X., Lin, J., Wong, I. N., Lo, H. H., Wang, J., Qu, L., Wong, V. K. W., Chung, S. K., & Law, B. Y. K. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107395 · Cited by 19
Progress in the application of novel inflammatory indicators in chronic kidney disease
Gao, W., Wang, X., Zou, Y., Wang, S., Dou, J., & Qian, S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1500166 · Cited by 18
Shnayder, N. A., Ashkhotov, A. V., Trefilova, V. V., Nurgaliev, Z. A., Novitsky, M. A., Петрова, М. М., Narodova, E. A., Al-Zamil, M., Chumakova, G. A., Garganeeva, N. P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097692 · Cited by 21
Long, J., Xu, P., Chen, J., Liao, J., Sun, D., Xiang, Z., Ma, H., Duan, H., Ju, M., & Ouyang, Y. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156404 · Cited by 20
Liu, L., Yang, X., Yang, C. Z., Tian, Y., Li, W., Xia, L., & Liu, H. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.031 · Cited by 20
Catapano, P., Luciano, M., Cipolla, S., D'Amico, D., Cirino, A., Corte, M. C. D., Sampogna, G., & Fiorillo, A. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100922 · Cited by 24
“…the exposure to these pollutants is linked to depressive or psychotic spectrum disorders, increasing inflammatory levels in both human and animal models, mainly through the inflammatory pathways, thus confirming the relationship between inflammation and mental disorders (Harsanyi et al., 2022).”
(2024) · doi:10.3389/fpsyt.2024.1442954 · Cited by 15
Liang, J., Zhang, J., Sun, J., Liang, Q., Zhan, Y., Yang, Z., Zhang, Y., Jin, L., Hu, C., & Zhao, Y. (2025) · Food & Function · doi:10.1039/d5fo00226e · Cited by 19
Inflammatory Blood Signature Related to Common Psychological Comorbidity in Chronic Pain
Karshikoff, B., Wåhlén, K., Åström, J., Lekander, M., Holmström, L., & Wicksell, R. K. (2023) · Biomedicines · doi:10.3390/biomedicines11030713 · Cited by 17
Association between depression and macrovascular disease: a mini review
Zhao, S., Zhu, L., & Yang, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1215173 · Cited by 20
“In addition, autonomic nervous dysfunction and neurohormone imbalance, inflammatory reaction and hippocampal structural alterations are all significant factors that contribute to the complex and bidirectional association between DM and depression (40, 50).”
BackgroundPatel, R. S., Krause‐Hauch, M., Kenney, K., Miles, S. R., Nakase‐Richardson, R., & Patel, N. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031473 · Cited by 15
“Electroencephalography (EEG) measurement of gamma and theta bands [96] and presence of cytokines [97] are proposed as biomarkers to help with the diagnosis of depression.”
BackgroundSabarathinam, S. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173805 · Cited by 15
Understanding genetic variants in context
Sinnott-Armstrong, N., Fields, S., Roth, F. P., Starita, L. M., Trapnell, C., Villén, J., Fowler, D. M., & Queitsch, C. (2024) · eLife · doi:10.7554/elife.88231 · Cited by 16
Chen, Y., Chen, X., Zhang, J., Zhang, X., Wang, D., Lu, N., Wang, C., Yue, Y., & Yuan, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118098 · Cited by 16
Yu, H., Li, R., Liang, X., Yang, W., Guo, L., Liu, L., Tan, Q., & Peng, Z. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06277-y · Cited by 15
Yu, X., Yu, X., Yang, Y., Cheng, W., Shi, M., Chen, L., Zhang, X., & Xu, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s511931 · Cited by 13
“Inflammatory response is important for the pathogenesis of depression, 4,49–51 in which the NLRP3 inflammasome plays a key role.”
Mechanism of Microbiota-Gut-Brain in Perimenopausal Depression: An Inflammatory Perspective
Yu, X., Zuo, Y., Yang, Y., Cheng, W., Shi, M., Cheng, L., Shao, Q., Xu, Y., & Chen, L. (2025) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2025.10011 · Cited by 13
“NF-κ B translocates to the nucleus, upregulating the transcription and expression of precursor proteins such as NLRP3, pro-IL-1 β and pro-IL-18 (Ref.”
Oral Lichen Planus and Systemic Diseases
Warnakulasuriya, S., Ramos‐García, P., & González‐Moles, M. Á. (2025) · Journal of Dental Research · doi:10.1177/00220345251385966 · Cited by 20
“There is a biological plausibility underlying this association: emotional disorders and chronic stress favor the release of cytokines and promote a systemic proinflammatory state, which could trigger or exacerbate flare-ups in OLP patients (Harsanyi et al. 2022).”
Wang, P., Li, Y., Song, Y., Gao, Y. Z., Hao, C., Zhou, Y., Bao, S., Guo, J., & Li, X. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14644 · Cited by 17
“7 Currently, the chronic unpredictable mild stress (CUMS) model is widely used to investigate the mechanism and etiology of the animal model of depression, 8 because CUMS can lead to immu-noinflammatory activation, which is known to induce psychiatric disorders.”
Cuomo, A., Aguglia, A., Berardis, D. D., Ventriglio, A., Gesi, C., & Fagiolini, A. M. (2024) · Annals of General Psychiatry · doi:10.1186/s12991-024-00505-1 · Cited by 13
“(i) Lack of objective measures, unlike some physical illnesses, as there are no clear biomarkers or diagnostic tests for depression [11].”
BackgroundPredictive Value of Inflammatory Biomarkers in Assessing Major Depression in Adults
Gavril, R. S., Dobrin, R., Pînzariu, A. C., Moscalu, M., Grigore, R. G., Iacob, V. T., Bejenariu, A. C., Popescu, E. R., Gavril, R., Gireadă, B., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12112501 · Cited by 15
“An increasing number of studies suggest that involvement in religious practices can provide individuals with a sense of belonging, shared beliefs, and social identity, which may be linked to improved mental well-being [24].”
Association between systemic inflammatory markers and depression: A meta-analysis
Jiang, X., Pei, J., Diao, H., He, Q., Zhu, T., Liu, Q., Cui, Y., Fang, F., & Cui, W. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.07.005 · Cited by 12
Cardiovascular disease and depression: a bidirectional relationship and its clinical implications
Wu, J., Tian, Z., Qi, Z., Liu, X., & Yu, P. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1675680 · Cited by 16
Zhang, S., Xu, Y., & Xia, Y. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.02.002 · Cited by 15
Giatti, S., Cioffi, L., Diviccaro, S., Chrostek, G., Piazza, R., & Melcangi, R. C. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04592-9 · Cited by 10
Research progress on the mechanism of antidepressant effect of salidroside
Ao, W., Gao, W., & Li, T. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115205 · Cited by 10
Nazir, M. M., Ghaffar, W., Mustafa, G., Saeed, S., Ijaz, M. U., & Ashraf, A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04464-6 · Cited by 15
“Neuroinflammation operates as an essential connection point between digestive system and nervous system functions because it controls how mental health interacts with physical health among patients who experience depression (Table 2) (Harsanyi et al. 2022).”
InfluentialZhang, Y., Ye, S., Zhang, Y., Sun, H., Zhao, X., Shen, X., & Wu, L. (2023) · Journal of Dental Sciences · doi:10.1016/j.jds.2023.06.003 · Cited by 12
Małujło-Balcerska, E., & Pietras, T. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.01.026 · Cited by 11
Pérez-Fernández, M., Suárez-Rojas, I., Bai, X., Martínez-Martel, I., Ciaffaglione, V., Pittalà, V., Salerno, L., & Pol, O. (2023) · Antioxidants · doi:10.3390/antiox12101794 · Cited by 9
“These data propose the use of 1m, 1a, 1b, and DMF, especially 1m, as new effective treatments for inflammatory pain and related emotional syndromes.”
MethodNeuropathological implication of high blood bilirubin in patients and model rats with depression
Gao, Y., Ling, Y., Li, J., Xu, Y., Ge, J., & Xia, Q. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111028 · Cited by 12
“Several studies have provided evidence for a significant involvement of inflammation and neuronal death in the neurotoxic effects of bilirubin; nevertheless, the underlying mechanism remains unidentified.”
BackgroundGutiérrez-Rojas, L., Vendrell-Serres, J., Ramos‐Quiroga, J. A., Etxeandia-Pradera, J.-I., Aguilar, E. J., de Santiago-Díaz, A. I., Hernández-Huerta, D., Tordera, V., Ventoso, C. V., Bolívar, M., et al. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241267837 · Cited by 13
“Perhaps, in the future, personalized psychiatry could be guided by genetic markers (Müller, 2020) and biomarkers as indicators of inflammatory status (Harsanyi et al., 2022).”
Neurobiology and medico-legal aspects of suicides among older adults: a narrative review
Sessa, F., Polito, R., Rosi, G. L., Salerno, M., Esposito, M., Pisanelli, D., Ministeri, F., Messina, A., Carotenuto, M., Chieffi, S., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1449526 · Cited by 13
Tsuboi, H., Sakakibara, H., Minamida, Y., Tsujiguchi, H., Hara, A., Suzuki, K., Miyagi, S., Nakamura, M., Takazawa, C., Kannon, T., et al. (2024) · BioPsychoSocial Medicine · doi:10.1186/s13030-024-00317-5 · Cited by 13
“A review article noted that the IL-12 serum/plasma level may be clinically valuable as part of a complex diagnostic approach to depression, although this must be carefully interpreted, taking into account confounders that can alter the same pro-inflammatory pathways and overlap with each other [58].”
BackgroundMałujło-Balcerska, E., & Pietras, T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196163 · Cited by 12
“There is evidence that depressive disorder is characterized by increased activity of immune cells and increased levels of proinflammatory cytokines, especially pivotal cytokines such as interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ [3].”
Chen, Y., Guo, M., Wang, Z., Mo, X., Hu, F., & Du, Y. (2024) · Microchimica Acta · doi:10.1007/s00604-024-06260-0 · Cited by 9
The Roles of Long Noncoding RNA in Depression
Wang, S., Tang, L., Huang, N., & Wang, H. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2811321 · Cited by 9
“This is because individuals with early onset depression are less likely to complete secondary education (2–3 times), and this population has a higher unemployment rate (29% at age 40) than that of the general population [4,5].”
BackgroundXue, H., Chen, J., & Fan, W. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.006 · Cited by 10
Wang, X., Zhang, P., Yan, J., Huang, J., Shen, Y., He, H., & Dou, H. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01333-2 · Cited by 13
Li, S., Nan, W., Peng, Z., Huang, Q., Chen, Q., & He, B. (2025) · European Journal of Psychotraumatology · doi:10.1080/20008066.2025.2450109 · Cited by 9
“Moreover, numerous studies have shown that inflammation serves as an increased risk for the development of depression (Harsanyi et al., 2023).”
Sousa, D. D. N., Azevedo, M. D. A., dos Santos, M. L., Borges, T. K. D. S., de Oliveira, D. M., & Caldas, E. D. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01650-6 · Cited by 13
“In the same way, high levels of IL-1β and Tumor Necrosis Factor (TNF) were associated with severe depression and suicidal ideation (Harsanyi et al. 2022; Liu et al. 2024).”
The Evolving Landscape of Host Biomarkers for Diagnosis and Monitoring of Tuberculosis
Cui, Y., Li, H., Liu, T., Zhong, R., Guo, J., Du, J., & Pang, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13092076 · Cited by 8
“In disease, they drive pathology (e.g., TNF-α in rheumatoid arthritis) and can serve as therapeutic targets (e.g., anti-TNF mAbs) or diagnostic markers (e.g., CRP) [75,76].”
Porta, C. L., Plum, T., Palme, R., Mack, M., & Tappe‐Theodor, A. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.025 · Cited by 9
Taccardi, D., Chiesa, A., Maiorani, C., Pardo, A., Lombardo, G., Scribante, A., Sabatini, S., & Butera, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154524 · Cited by 15
Ramirez, E. B. D., Arnold, M. E., & Schank, J. R. (2023) · Addiction Biology · doi:10.1111/adb.13357 · Cited by 10
Li, J., Li, X., Liu, J., Wei, S., Zhou, D., Wang, D., & Zhang, X. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111184 · Cited by 7
Wu, L., Deng, Y., Yu, L., Peng, W., Li, Y., Feng, Y., Chen, L., Huang, P., & Chen, B. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70375 · Cited by 7
“Besides the HPA axis, immune responses have also been involved in depression [40].”
Mitincu-Caramfil, S.-D., Drima, E. P., Pascu, L. S., Moroianu, L.-A., Gherghiceanu, F., Popoviciu, M. S., & Stoian, A. P. (2025) · Journal of Mind and Medical Sciences · doi:10.3390/jmms12010024 · Cited by 11
BDNF mediates the heart-brain axis: implications for cardiovascular diseases and mental disorders
Fan, H., Duan, J., Liu, W., Yang, C., & Yang, L. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02016-w · Cited by 11
“Inflam - matory factors, which are implicated in the development of CVDs, are also closely associated with MD such as depression [14, 15 ].”
Wei, Y., Zhang, C., Sun, B., Lin, J., Zhao, Y., Chen, Y., Gao, H., Li, J., Li, G., Feng, J., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119530 · Cited by 13
Oh, H., Kong, N. Y., Jung, S.-W., Kim, H.-C., Kim, S., Kang, J., & Lee, H. (2025) · Psychiatry Investigation · doi:10.30773/pi.2025.0013 · Cited by 7
Song, T.-M., Chen, X., Chen, X.-H., Tan, S.-J., Song, C.-H., Fan, L., Li, J.-Y., & Li, H.-L. (2025) · Depression and Anxiety · doi:10.1155/da/5566680 · Cited by 8
“A prolonged imbalance between anti-and pro-in fl ammatory processes exacerbates both frailty and depressive outcomes [74].”
Paraniak-Gieszczyk, B., & Ogłodek, E. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199636 · Cited by 12
“Currently, antibodies and IL-12 inhibitors are being tested as potential targeted therapies [37].”
Kalaga, P., & Ray, S. K. (2025) · Brain Sciences · doi:10.3390/brainsci15020197 · Cited by 6
“Increased presence of pro-inflammatory cytokines has already been implicated in the progression of MDD [71].”
Rotsiamis, N., Rompoti, N., Liakou, A. Ι., Tsantes, A. G., Bonovas, S., Samonis, G., Ιωάννου, Π., Mpakosi, A., Koumprentziotis, I., Tsamtsouri, L., et al. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04143-9 · Cited by 6
“It could also indicate a possible common pathogenetic pathway between HS and depression, since chronic inflamma - tion and activation of pro-inflammatory cytokines, such as IFNγ, TNFa, IL-1β, IL-6, and IL-17, have been identified in both diseases [30].”
Zhao, K., Xiang, L., Yang, S., Chen, X., Yang, X., Dong, J., Wu, S., Yang, S., Zhang, M., & Hu, W. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70406 · Cited by 7
“Emerging evidence suggests that targeting neuroinflammation could offer a potential strategy for the prevention and treatment of depression [9, 10].”
Biomarkers and Mental Disorders: A Relevance Analysis Using a Random Forest Algorithm
Rodolpho, J. M. D. A., de Godoy, K. F., Fragelli, B. D. D. L., Bianchi, J., Duarte, F. O., Camillo, L., da Silva, G. G., de Andrade, P. H. M., Prado, J. A., Speglich, C., et al. (2025) · Biomolecules · doi:10.3390/biom15060793 · Cited by 8
Li, P., Yue, X., Li, C., Yao, L., & Su, Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1596940 · Cited by 8
“With the constant progress and wide application of clinical testing and imaging technologies, the research on the use of hematological testing and imaging interpretation in the field of non-organic diseases, such as cognitive and mood disorders, is becoming more and more in-depth (7–9).”
Amawi, H. A., Alsheyab, S., Hammad, A. M., Alhazaimeh, R., Maklouf, T., Al‐Trad, B., Almarghalani, D. A., Alzahrani, M. S., Ashby, C. R., & Tiwari, A. K. (2025) · Genes Brain & Behavior · doi:10.1111/gbb.70037 · Cited by 6
Małujło-Balcerska, E., Pietras, T., & Śmigielski, W. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00548-3 · Cited by 8
“High levels of cytokines, such as IL-1, IL-6, TNF-ɑ , IFN-ɣ , IL-4, and IL-10, have also been found to be biomarkers of depressive disorder [3].”
BackgroundDing, H., Wang, Y., Gao, Y., Ye, F., Yao, K., Cao, L., Liu, Z., Wang, G., & Zhang, J. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116950 · Cited by 6
Chen, J., Xie, X., Lin, M., Han, H. R., Wang, T., Lei, Q., & He, R. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1372386 · Cited by 7
Associations of ethylene oxide exposure with depression in American adults
Wang, M., Liu, C., Liu, Q., & Bai, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-64908-6 · Cited by 6
Gilani, M., Abak, N., & Saberian, M. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173897 · Cited by 6
Wang, L., Wang, M., Liu, X., Tian, J., Zhang, L., & Li, Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.023 · Cited by 7
Liu, L., Wang, J., Hu, S., Shao, J., Ding, F., & Yu, W. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.151 · Cited by 8
Jiang, M., Li, X., & Lu, Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119515 · Cited by 9
Metadata
- Authors
- Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M.
- Affiliations
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia
- Comenius University Bratislava (SK)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-12-29
- Volume
- 24
- Issue
- 1
- Pages
- 578
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9820159
- OpenAlex
- W4313361124
- Semantic Scholar
- ff8ea139489ad0c55b6a066d65875eb9feda6c69
- Cited by
- 299
- References
- 218
- Citations by year
- 2026: 71 · 2025: 117 · 2024: 82 · 2023: 29
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, biomarkers, cytokines, inflammation, major depressive disorder, oxidative stress, neuropeptides, stress response, animal models of depression, depression diagnosis, depression pathogenesis
- MeSH terms
- Animals, Depression, Depressive Disorder, Major, Major Depressive Disorder, Inflammation, Quality of Life, Biomarkers, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
